» Articles » PMID: 37981725

The Asian Thyroid Working Group, from 2017 to 2023

Overview
Date 2023 Nov 20
PMID 37981725
Authors
Affiliations
Soon will be listed here.
Abstract

The Asian Thyroid Working Group was founded in 2017 at the 12th Asia Oceania Thyroid Association (AOTA) Congress in Busan, Korea. This group activity aims to characterize Asian thyroid nodule practice and establish strict diagnostic criteria for thyroid carcinomas, a reporting system for thyroid fine needle aspiration cytology without the aid of gene panel tests, and new clinical guidelines appropriate to conservative Asian thyroid nodule practice based on scientific evidence obtained from Asian patient cohorts. Asian thyroid nodule practice is usually designed for patient-centered clinical practice, which is based on the Hippocratic Oath, "First do not harm patients," and an oriental filial piety "Do not harm one's own body because it is a precious gift from parents," which is remote from defensive medical practice in the West where physicians, including pathologists, suffer from severe malpractice climate. Furthermore, Asian practice emphasizes the importance of resource management in navigating the overdiagnosis of low-risk thyroid carcinomas. This article summarizes the Asian Thyroid Working Group activities in the past 7 years, from 2017 to 2023, highlighting the diversity of thyroid nodule practice between Asia and the West and the background reasons why Asian clinicians and pathologists modified Western systems significantly.

Citing Articles

Fine needle aspiration cytology diagnoses of follicular thyroid carcinoma: results from a multicenter study in Asia.

Na H, Higuchi M, Satoh S, Kameyama K, Jung C, Shin S J Pathol Transl Med. 2024; 58(6):331-340.

PMID: 39557411 PMC: 11573475. DOI: 10.4132/jptm.2024.10.12.


Aggressive Types of Malignant Thyroid Neoplasms.

Boudina M, Zisimopoulou E, Xirou P, Chrisoulidou A J Clin Med. 2024; 13(20).

PMID: 39458070 PMC: 11508432. DOI: 10.3390/jcm13206119.


Welcoming the new, revisiting the old: a brief glance at cytopathology reporting systems for lung, pancreas, and thyroid.

Luis R, Thirunavukkarasu B, Jain D, Canberk S J Pathol Transl Med. 2024; 58(4):165-173.

PMID: 39026441 PMC: 11261173. DOI: 10.4132/jptm.2024.06.11.

References
1.
Odate T, Oishi N, Vuong H, Mochizuki K, Kondo T . Genetic differences in follicular thyroid carcinoma between Asian and Western countries: a systematic review. Gland Surg. 2020; 9(5):1813-1826. PMC: 7667107. DOI: 10.21037/gs-20-356. View

2.
Rana C, Vuong H, Nguyen T, Nguyen H, Jung C, Kakudo K . The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification. Thyroid. 2021; 31(10):1502-1513. DOI: 10.1089/thy.2021.0158. View

3.
Liu C, Chen C, Bychkov A, Agarwal S, Zhu Y, Hang J . Constitutive Cytomorphologic Features of Medullary Thyroid Carcinoma Using Different Staining Methods. Diagnostics (Basel). 2021; 11(8). PMC: 8392035. DOI: 10.3390/diagnostics11081396. View

4.
Ghossein R, Barletta J, Bullock M, Johnson S, Kakudo K, Lam A . Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2020; 110:62-72. PMC: 7943644. DOI: 10.1016/j.humpath.2020.08.009. View

5.
Kakudo K, Kameyama K, Miyauchi A, Nakamura H . Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association. Endocr J. 2014; 61(6):539-52. DOI: 10.1507/endocrj.ej13-0494. View